Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children.
Latest Information Update: 16 Jun 2025
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
Most Recent Events
- 10 Jun 2025 Planned number of patients changed from 200 to 210.
- 10 Jun 2025 Planned End Date changed from 31 Aug 2025 to 31 Dec 2025.
- 10 Jun 2025 Planned primary completion date changed from 31 Aug 2025 to 31 Dec 2025.